Office of the Secretary (OS)

Collaboration Title	Collaboration Type	HHS Participating Agencies	NIH Participating Institutes/ Centers/ Office of the Director	Year Collaboration Originated
Biodefense Coordination Team (BCT)	Committee, Advisory Group, or Work Group	CDC, FDA, OS	OD/ OSP	2019
Bioeconomy Interagency Working Group	Committee, Advisory Group, or Work Group	FDA, OS	OD/ OSP	2019
Biological Select Agents and Toxins Interagency Policy Committee (BSAT PPC)	Committee, Advisory Group, or Work Group	CDC, FDA, OS	NIAID, OD/ OSP
Biological Select Agents and Toxins sub-Interagency Policy Committee (BSAT Sub-PPC)	Committee, Advisory Group, or Work Group	CDC, FDA, OS	NIAID, OD/ OSP
Blood, Organ, and Tissue Safety Committee (BOTSEC)	Committee, Advisory Group, or Work Group	CDC, CMS, FDA, OS	CC, NHLBI	1997
Blood, Organ, and Tissue Senior Executive Council (BOTSEC)	Committee, Advisory Group, or Work Group	AHRQ, CDC, CMS, FDA, HRSA, OS	CC, NIAID	2012

Funding levels reported in the Fiscal Year 2020 Intra-Agency Collaborations Reporting System (CRS) may not be consistent with funding levels reported under the Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) at the NIH Office of Budget Website at http://report.nih.gov/categorical_spending.aspx. The current process, implemented in 2008 through the Research, Condition, and Disease Categorization (RCDC) system, uses sophisticated text data mining (categorizing and clustering using words and multiword phrases) in conjunction with NIH-wide definitions used to match projects to categories. RCDC use of data mining improves consistency and eliminates the wide variability in defining the research categories reported. The definitions are a list of terms and concepts selected by NIH scientific experts to define a research category. The research category levels represent the NIH’s best estimates based on the category definitions.